Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
DAGO2 produced 3-year overall survival of 52% versus 35% with CPX-351 in older patients with non-adverse-risk AML in a 439-patient randomized comparison.
Hematology April 28th 2026
Mayo Clinic Labs
Hereditary TTP, an ultra-rare ADAMTS13 deficiency affecting roughly one in a million, is now managed with weekly recombinant ADAMTS13 infusions in a pediatric outpatient setting.
Medical Xpress
The new method, called MethylScan, works by analyzing cell-free DNA (cfDNA), which carries molecular signals that reflect what is happening throughout the body.
Hematology April 14th 2026
Medical Professionals Reference (MPR)
A patient harmed by their own noncompliance may still file a medical malpractice case. Luckily, though, with proper record-keeping you can generally prevail in this sort of case.
Cardiology April 10th 2026
ReachMD
“The idea of preserving and reducing thrombosis without increasing bleeding is very, very exciting.” — Roxana Mehran, MD, SCAI 2025
Cardiology March 25th 2026
“Extreme endurance exercise pushes red blood cells toward accelerated aging through mechanisms that mirror what we observe during blood storage.” — Angelo D’Alessandro, PhD, University of Colorado Anschutz
Cardiology March 17th 2026